➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Medtronic
Moodys
McKesson
Merck
Dow

Last Updated: August 14, 2020

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR METHAMPHETAMINE HYDROCHLORIDE

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

505(b)(2) Clinical Trials for Methamphetamine Hydrochloride

This table shows clinical trials for potential 505(b)(2) applications. See the next table for all clinical trials
Trial Type Trial ID Title Status Sponsor Phase Start Date Summary
OTC NCT00829634 Steady State Kinetics of l-Methamphetamine and Validation of Sensitivity of Dose Estimation Completed National Institutes of Health (NIH) N/A 2008-10-01 The intent of this study is to see if the rate that the body breaks down l-methamphetamine (l-MA) could be used as an accurate estimate for the rate that the body breaks down d-methamphetamine (d-MA). l-MA is sold over the counter as a nasal decongestant where as d-MA is the commonly abused form of methamphetamine.
OTC NCT00829634 Steady State Kinetics of l-Methamphetamine and Validation of Sensitivity of Dose Estimation Completed San Francisco General Hospital N/A 2008-10-01 The intent of this study is to see if the rate that the body breaks down l-methamphetamine (l-MA) could be used as an accurate estimate for the rate that the body breaks down d-methamphetamine (d-MA). l-MA is sold over the counter as a nasal decongestant where as d-MA is the commonly abused form of methamphetamine.
OTC NCT00829634 Steady State Kinetics of l-Methamphetamine and Validation of Sensitivity of Dose Estimation Completed University of California, San Francisco N/A 2008-10-01 The intent of this study is to see if the rate that the body breaks down l-methamphetamine (l-MA) could be used as an accurate estimate for the rate that the body breaks down d-methamphetamine (d-MA). l-MA is sold over the counter as a nasal decongestant where as d-MA is the commonly abused form of methamphetamine.
OTC NCT00829634 Steady State Kinetics of l-Methamphetamine and Validation of Sensitivity of Dose Estimation Completed California Pacific Medical Center Research Institute N/A 2008-10-01 The intent of this study is to see if the rate that the body breaks down l-methamphetamine (l-MA) could be used as an accurate estimate for the rate that the body breaks down d-methamphetamine (d-MA). l-MA is sold over the counter as a nasal decongestant where as d-MA is the commonly abused form of methamphetamine.
>Trial Type >Trial ID >Title >Status >Phase >Start Date >Summary

All Clinical Trials for Methamphetamine Hydrochloride

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00000241 Flupenthixol Decanoate in Methamphetamine Smoking - 1 Completed Friends Research Institute, Inc. Phase 2 1994-02-01 The purpose of this study is to evaluate the safety and efficacy of flupenthixol decanoate for treatment of methamphetamine dependence. Also, study will compare flupenthixol with desipramine in blocking methamphetamine self-administration.
NCT00000241 Flupenthixol Decanoate in Methamphetamine Smoking - 1 Completed National Institute on Drug Abuse (NIDA) Phase 2 1994-02-01 The purpose of this study is to evaluate the safety and efficacy of flupenthixol decanoate for treatment of methamphetamine dependence. Also, study will compare flupenthixol with desipramine in blocking methamphetamine self-administration.
NCT00000321 Methamphetamine Abuse Treatment in Patients With AIDS - 1 Completed Friends Research Institute, Inc. Phase 4 1996-10-01 The purpose of this study is to evaluate the efficacy of desipramine, sertraline, and placebo on methamphetamine dependent gay men with AIDS.
NCT00000321 Methamphetamine Abuse Treatment in Patients With AIDS - 1 Completed National Institute on Drug Abuse (NIDA) Phase 4 1996-10-01 The purpose of this study is to evaluate the efficacy of desipramine, sertraline, and placebo on methamphetamine dependent gay men with AIDS.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Methamphetamine Hydrochloride

Condition Name

Condition Name for Methamphetamine Hydrochloride
Intervention Trials
Methamphetamine Dependence 43
Substance Abuse 16
Methamphetamine Abuse 16
Amphetamine-Related Disorders 10
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Methamphetamine Hydrochloride
Intervention Trials
Substance-Related Disorders 27
Amphetamine-Related Disorders 19
HIV Infections 7
Disease 6
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Methamphetamine Hydrochloride

Trials by Country

Trials by Country for Methamphetamine Hydrochloride
Location Trials
United States 136
China 4
Malaysia 3
Thailand 2
Canada 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Methamphetamine Hydrochloride
Location Trials
California 50
Texas 14
Arkansas 8
Utah 7
New York 6
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Methamphetamine Hydrochloride

Clinical Trial Phase

Clinical Trial Phase for Methamphetamine Hydrochloride
Clinical Trial Phase Trials
Phase 4 18
Phase 3 6
Phase 2/Phase 3 2
[disabled in preview] 48
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Methamphetamine Hydrochloride
Clinical Trial Phase Trials
Completed 63
Recruiting 18
Unknown status 11
[disabled in preview] 8
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Methamphetamine Hydrochloride

Sponsor Name

Sponsor Name for Methamphetamine Hydrochloride
Sponsor Trials
National Institute on Drug Abuse (NIDA) 60
University of California, Los Angeles 20
Baylor College of Medicine 8
[disabled in preview] 8
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Methamphetamine Hydrochloride
Sponsor Trials
Other 129
NIH 63
Industry 11
[disabled in preview] 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Colorcon
AstraZeneca
Boehringer Ingelheim
Harvard Business School
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.